Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pregabalin for prevention and reduction of post-dural puncture headache after accidental dural puncture in obstetric patients
ACTRN12616000016437Phase 4Terminated
- Sponsor
- King Edward Memorial Hospital for Women
- Start
- Jul 2016
- Modality
- Small Molecules
- Countries
- 2
01
Overview
Phase 4, randomised, double-blind trial in post-dural puncture headache (PDPH) comparing Pregabalin with Placebo (2 arms). Primary endpoint: Severity of post-dural puncture headache. Started Jul 2016; status: terminated.
02
Drugs
pregabalin
03
Conditions
post-dural puncture headache (PDPH)
Beyond the preview
Go deeper on ACTRN12616000016437.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12616000016437.